These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 5530511)

  • 41. Studies on measles in Thailand. V. Protection against a measles outbreak by previous vaccination in an isolated institution.
    Sangkawibha N; Tuchinda P; Bukkavesa S; Osatanonda P; Ueda S; Okuno Y
    Biken J; 1971 Dec; 14(4):413-7. PubMed ID: 5149999
    [No Abstract]   [Full Text] [Related]  

  • 42. Response to measles, mumps and rubella vaccine in paediatric bone marrow transplant recipients.
    King SM; Saunders EF; Petric M; Gold R
    Bone Marrow Transplant; 1996 Apr; 17(4):633-6. PubMed ID: 8722367
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Studies on the combined use of killed and live measles vaccines. IV. Fou years follow-up.
    Ueda S; Takahashi M; Hosai H; Yamanishi K; Okuno Y
    Biken J; 1969 Jun; 12(2):69-75. PubMed ID: 5346351
    [No Abstract]   [Full Text] [Related]  

  • 44. Effects and side effects of a new trivalent combined measles-mumps-rubella (MMR) vaccine.
    Isozaki M; Kuno-Sakai H; Hoshi N; Takesue R; Takakura I; Kimura M; Hikino M; Mitsuda M
    Tokai J Exp Clin Med; 1982 Sep; 7(5):547-50. PubMed ID: 7182947
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Live measles vaccine from a further attenuated strain SEVAC.
    Mares I; Drevo M; Adam E; Kubátová M; Casny J
    Prog Immunobiol Stand; 1967; 3():188-91. PubMed ID: 5379938
    [No Abstract]   [Full Text] [Related]  

  • 46. Measles vaccine reactions in a virgin population.
    Black FL; Woodall JP; Pinheiro FD
    Am J Epidemiol; 1969 Feb; 89(2):168-75. PubMed ID: 5765956
    [No Abstract]   [Full Text] [Related]  

  • 47. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K; Nicoara C; Germann D; Matter L
    Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Studies on live mumps virus vaccine. IV. Clinical and serological follow-up 2 year and 3 years after vaccination.
    Yamanishi K; Takahashi M; Kurimura T; Ueda S; Suzuki N
    Biken J; 1971 Sep; 14(3):259-65. PubMed ID: 5156905
    [No Abstract]   [Full Text] [Related]  

  • 49. A study of the protective effect of live measles vaccines 13 to 27 months after vaccination.
    Sejda J; Helcl J; Strauss J; Zdrazílek J; Mírovský J
    J Hyg Epidemiol Microbiol Immunol; 1968; 12(2):187-91. PubMed ID: 5752748
    [No Abstract]   [Full Text] [Related]  

  • 50. [Clinical and serological studies with a live further attenuated measles vaccine (Moraten) in Chile].
    Ristori C; Boccardo H; Borgoño JM; Greiber R; Heras E; Carrillo B; Solari G; Concha F
    Rev Med Chil; 1970 Jan; 98(1):42-5. PubMed ID: 4157374
    [No Abstract]   [Full Text] [Related]  

  • 51. An extremely attenuated, live measles virus vaccine (CAM-EX). Persistence of low titer-antibody in institutionalized children with psychomotor retardation after vaccination.
    Ueda K; Hashiguchi K; Nakashima F; Ueda S; Takahashi M
    Biken J; 1981 Sep; 24(3):119-22. PubMed ID: 7337678
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Studies on live mumps virus vaccine. V. Development of a new mumps vaccine "AM 9" by plaque cloning.
    Yamanishi K; Takahashi M; Ueda S; Minekawa Y; Ogino T
    Biken J; 1973 Dec; 16(4):161-6. PubMed ID: 4799208
    [No Abstract]   [Full Text] [Related]  

  • 53. Studies on the modification of the live AIK measles vaccine. II. Development and evaluation of the live AIK-C measles vaccine.
    Makino S; Sasaki K; Nakamura N; Nakagawa M; Nakajima S
    Kitasato Arch Exp Med; 1974 Jun; 47(1-2):13-21. PubMed ID: 4476032
    [No Abstract]   [Full Text] [Related]  

  • 54. [Clinical and immunological prospective study of the measles live virus vaccine].
    Sujoy E; Blaksley JC; Shepherd G; Simsolo V; Palais L; Pizzia A; Becker D; Behar M; Morgenstern O
    Arch Argent Pediatr; 1966; 63(7):260-5. PubMed ID: 5990418
    [No Abstract]   [Full Text] [Related]  

  • 55. [Anti-mumps vaccination with live attenuated vaccine in a children's community].
    Drouhet V; Celers J; Minvielle A; Lévy-Thierry S
    Ann Pediatr (Paris); 1971 Apr; 18(4):277-85. PubMed ID: 5574000
    [No Abstract]   [Full Text] [Related]  

  • 56. [Specific prevention of measles in Rumania. V. Studies on an attenuated live measles virus vaccine prepared at the Stefan S. Nicolau Institute of Virology and administered in various ways].
    Cajal N; Cepleanu M; Cernesc C; Sorodoc Y; Tigăeru N; Biberi-Moroianu S; Cuciu D; Brebenel G; Vucu E; Petrescu A
    Stud Cercet Virusol; 1973; 24(5):349-56. PubMed ID: 4747453
    [No Abstract]   [Full Text] [Related]  

  • 57. [Rubeola vaccination. Serological and clinical studies of the "Cendehill strain" live vaccine].
    Zellweger U; Kayser FH; Hitzig WH
    Dtsch Med Wochenschr; 1969 Mar; 94(10):461-5. PubMed ID: 5764887
    [No Abstract]   [Full Text] [Related]  

  • 58. Clinical and serological studies in Mexico with live attenuated mumps virus vaccine. (Jerry Lynn strain).
    Ramos Alvarez M; Bessudo L
    Rev Invest Salud Publica; 1972; 32(2):104-8. PubMed ID: 4584449
    [No Abstract]   [Full Text] [Related]  

  • 59. Serological survey of measles immunization with the Rimevax--RIT--vaccine in a Romanian district.
    Ciufecu E; Dincă L; Serbănescu R; Dinculescu M; Găleşanu M
    Arch Roum Pathol Exp Microbiol; 1980; 39(1):31-40. PubMed ID: 6996640
    [No Abstract]   [Full Text] [Related]  

  • 60. Investigation and appplication of the USSR AMS live measles vaccine from the ESC strain for mass vaccination against measles.
    Chumakov MP; Voroshilova MK; Grachev VP; Sinyak KM; Boiko VM; Seibil VB; Rodin VI; Piven GG
    J Hyg Epidemiol Microbiol Immunol; 1970; 14(1):1-18. PubMed ID: 4985647
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.